home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification
prev / next
 
 

registry of biomedical companies

  
  December 05, 2025
promoting the transfer of scientific know-how between industry and academia
  
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 395 active entries

Viwit Pharmaceuticals Limited

507 Block B, Yingjia Plaza, 3008 Gudai Road, Shang
201100
China

Phone: 86-21-37775618
Fax: 86-21-37775619
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

        Viwit Pharmaceutical Co., Ltd (Viwit) is a chemistry technology enterprise dedicated to the development and manufacturing of novel products in the fields of Finished Dosage Formulations, Active Pharmaceutical Ingredients and Fine Chemicals. All of our products are manufactured by ourselves, based on our core technologies.
       Innovation is the soul of Viwit. Respect of talents and dedication to the development of new technology/products are the foundation of our competitiveness and growth, and thus of our company's success. We are firmly aligned to our mission statement "VIWIT: Innovation for a better life".
       Viwit consists of six subsidiaries, including two integrated R&D centers and three cGMP production facilities. It covers a land area of 199,000 m2 and employs nearly 500 staffs, including more than 150 scientists, many with PhD or master degrees. All three production facilities are managed under cGMP and ICH quality systems, and are certified respectively by cFDA (China GMP 2010), ISO9001:2008, Mexican COFEPRIS, and World Health Organization.
       We now provide global customers several categories of high quality products with competitive price, including APIs, boronic acids, borane reagents, chiral reagents and intermediates. All new products, if involved in patents issues, are only for academic research, not for commercial use.

Our product offering:

Bortezomib179324-69-7
(1R)-(S)-Pinanediol 1-ammonium trifluoroacetate-3-methylbutane-1-boronate179324-87-9
Bortezomib-Pinanediol205393-22-2
N-(2-Pyrazinylcarbonyl)-L-phenylalanine
114457-94-2
Luliconazole187164-19-8
Varenicline free base249296-44-4
Varenicline hydrochloride230615-23-3
Varenicline tartrate 375815-87-5
Aprepitant170729-80-3
(2R,3S)-2-[(1R)-l-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-morpholine hydrochloride171482-05-6
(2R,3S)-2-[(1R)-l-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-morpholine, 4-methylbenzenesulfonate200000-59-5
Eletriptan hydrobromide177834-92-3
(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole143322-57-0
Brinzolamide138890-62-7
(S)-3,4-Dihydro-6-chloro-4-hydroxy-4H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide160982-16-1
Aliskiren hemifumarate173334-58-2
Cinacalcet Hydrochloride364782-34-3
Atazanavir198904-31-3
Atazanavir Sulphate229975-97-7
Sitagliptin 486460-32-6
Sitagliptin phosphate monohydrate654671-77-9
Foraprepitant172673-20-0
Fosaprepitant dimeglumine265121-04-8
Tetrabenzyl pyrophosphate(TBPP)990-91-0
Vildagliptin274901-16-5
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile207557-35-5
Rizatriptan144034-80-0
Rizatriptan benzoate145202-66-0
Sumatriptan103628-46-2
Sumatriptan succinate103628-48-4
Ocfentanil101343-69-5
MK677 (Inutamoren)159634-47-6
MK677 (Inutamoren),methanesulfonate159752-10-0
Dronedarone141626-36-0
Dronedarone Hydrochloride141625-93-6
Linagliptin668270-12-0
Gadobutrol138071-82-6
Gadoteric acid72573-82-1
(S)-2-chloro-1-(2,4-dichlorophenyl) ethyl methanesulfonate53984-39-7
(1S)-2chloro-1-(2,4-dichlorophenyl) ethanol 126534-31-4
2-(1H imidazole -1-yl)acetonitrile98873-55-3
L-PROLINAMIDE 7531-52-4
3-AMINO-1-HYDROXYADAMANTANE702-82-9
linagliptin668270-12-0
8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione 666816-98-4
(R)-3-aminopiperidine dihydrochloride334618-23-4
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione 853029-57-9
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one764667-65-4
2,4,5-Trifluorophenylacetic acid209995-38-0
2-[(2S,3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxylic acid tert-butyl ester198904-86-8
Mirabegron223673-61-8
(R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride521284-21-9
(R)-2-(4-aminophenethylamino)-1-phenylethanol hydrochloride521284-22-0
Rivaroxaban366789-02-8
2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione446292-07-5
2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione446292-08-6
[(1S,2R)-2-HYDROXY-3-[(2-METHYLPROPYL)AMINO]-1-(PHENYLM160232-08-6
Tris(o-tolyl)phosphine (TOTP)6163-58-2
Efinaconazole164650-44-6
4-Methylenepiperidine HCl144230-50-2
(2R)-1-(2,4-difluorophenyl)-2-(tetrahydro-2H-pyran-2-yloxy)propan-1-one126918-17-0
(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol133775-25-4
(2R,3S)-2-(2,4-Difluorophenyl)-3-methyl-[(1H-1,2,4-triazol-1-yl)methyl]oxirane127000-90-2
Gadoterate Meglumine92943-93-6
Cyclopropyl boronic acid411235-57-9
Methyl boronic acid 13061-96-6
Trimethyl boroxine(50 wt% in THF)823-96-1
(+)-B-Chlorodiisopinocampheylborane 60-65% solution in heptane112246-73-8
(-)-B-Chlorodiisopinocampheylborane 60-65% solution in heptane85116-37-6
(R)-(+)-2-(Diphenylhydroxymethyl)pyrrolidine22348-32-9
(S)-(-)-2-(Diphenylhydroxymethyl)pyrrolidine112068-01-6
(S)-Methyl Oxazaborolidine（S-CBS）112022-81-8
(R)-Methyl Oxazaborolidine（R-CBS）112022-83-0
133261-83-3 
(S)-1-(3,5-Bis-trifluoromethylphenyl)ethanol225920-05-8
(R)-1-(3,5-Bis-trifluoromethylphenyl)ethanol127852-28-2
(S)-1-(4-Bromophenyl)ethanol100760-04-1
(R)-1-(4-Bromophenyl)ethanol76155-78-7
(S)-1-(4-Chlorophenyl)ethanol99528-42-4
(R)-1-(4-Chlorophenyl)ethanol75968-40-0
(S)-1-(4-Fluorophenyl)ethanol101219-73-2
(R)-1-(4-Fluorophenyl)ethanol101219-68-5
(S)-1-(4-Cyanophenyl)ethanol101219-71-0
(R)-1-(4-Cyanophenyl)ethanol101219-69-6
(1R,2R,3S,5R)-(-)-2,3-Pinanediol22422-34-0
(1S,2S,3R,5S)-(+)-2,3-Pinanediol18680-27-8
(R)-(+)-1-(1-Naphthyl)ethanol 42177-25-3
(S)-(−)-1-(1-Naphthyl)ethanol 15914-84-8
(R)-Styrene oxide20780-53-4
(S)-Styrene oxide20780-54-5
(R)-2-Chloro-1-phenylethanol56751-12-3
(R)-(3-Chlorophenyl)oxirane62600-71-9
(R)-2-Chloro-1-(3-chlorophenyl)ethanol142763-10-8
(R)-(4-Fluorophenyl)oxirane134356-73-3
(R)-2-Chloro-1-(4-fluorophenyl)ethanol126534-43-8
(R)-(4-Methoxyphenyl)oxirane62600-73-1
(R)-2-Chloro-1-(4-methoxyphenyl)ethanol186345-05-1
(S)-1-(3-Nitrophenyl)propanol188770-83-4
(S)-(-)-1-Phenylethanol1445-91-6
(R)-(+)-1-Phenylethanol1517-69-7
 
(R)-(1-(4-Nitrophenyl))ethanol		58287-18-6
(R)-1-(Pyrid-3-yl)-2-chloroethanol173901-03-6
(R)-(4-Chlorophenyl)oxirane21019-51-2
(S)-(4-Chlorophenyl)oxirane97466-49-4
(R)-2-(1-Hydroxyethyl) pyridine 27911-63-3
 



Selected Categories:
Product Company   Service Company
Biotech
- Agriculture
- General
- Research
Pharmaceutical
- General
- Research
Contract
- Production

Last update of this entry: May 13, 2020

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2025 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.